Ma Liying, Guo Yanfang, Yuan Lin, Huang Yang, Sun Jianping, Qu Shuiling, Yu Xiaoling, Meng Zhefeng, He Xiang, Jiang Shibo, Shao Yiming
State Key Laboratory for Infectious Disease Control and Prevention, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China.
Retrovirology. 2009 May 14;6:45. doi: 10.1186/1742-4690-6-45.
HIV-1 CRF07_BC recombinant previously circulated mainly among the intravenous drug users (IDUs) in Xinjiang province of China and is currently spreading in the entire country. The aim of this study is to characterize the genotypic and phenotypic properties of HIV-1 CRF07_BC isolates in comparison with those of the subtype B' (Thailand B) which is prevalent in the former plasma donors (FPDs) in China.
Twelve HIV-1 CRF07_BC variants were isolated from the blood of the HIV-1-infected IDUs in Xinjiang province, and 20 subtype B' isolates were obtained from the FPDs in Anhui and Shanxi provinces of China. All the CRF07_BC viruses utilized CCR5 co-receptor, whereas 12 subtype B' viruses were R5-tropic, and the remaining B' isolates were dual (R5X4) tropic. CRF07_BC viruses had lower net charge value in the V3 loop and exhibited slower replication kinetics than subtype B' viruses. The number and location of the potential N-linked glycosylation sites in V1/V2 and the C2 region of the CRF07_BC viruses were significantly different from those of the subtype B' viruses.
The HIV-1 CRF07_BC recombinant strains with relatively lower net charges in the V3 loop exclusively utilize CCR5 co-receptor for infection and exhibit slow replication kinetics in the primary target cells, suggesting that CRF07_BC may be superior over B' and other HIV-1 subtypes in initiating infection in high-risk population. These findings have molecular implications for the adaptive evolution of HIV-1 circulating in China and the design of tailored therapeutic strategy for treatment of HIV-1 CRF07_BC infection.
HIV-1 CRF07_BC重组毒株先前主要在中国新疆维吾尔自治区的静脉注射吸毒者(IDU)中传播,目前正在全国范围内扩散。本研究的目的是与中国既往血浆捐献者(FPD)中流行的B'亚型(泰国B)相比,对HIV-1 CRF07_BC分离株的基因型和表型特性进行表征。
从中国新疆维吾尔自治区HIV-1感染的IDU血液中分离出12株HIV-1 CRF07_BC变异株,从中国安徽和山西省的FPD中获得20株B'亚型分离株。所有CRF07_BC病毒均利用CCR5共受体,而12株B'亚型病毒为R5嗜性,其余B'分离株为双嗜性(R5X4)。CRF07_BC病毒在V3环中的净电荷值较低,与B'亚型病毒相比,其复制动力学较慢。CRF07_BC病毒V1/V2和C2区域潜在N-连接糖基化位点的数量和位置与B'亚型病毒显著不同。
V3环中净电荷相对较低的HIV-1 CRF07_BC重组毒株仅利用CCR5共受体进行感染,在主要靶细胞中表现出缓慢的复制动力学,这表明CRF07_BC在高危人群中引发感染方面可能优于B'亚型和其他HIV-1亚型。这些发现对中国流行的HIV-1的适应性进化以及针对HIV-1 CRF07_BC感染的定制治疗策略的设计具有分子学意义。